BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shemesh A, Su Y, Calabrese DR, Chen D, Arakawa-hoyt J, Roybal KT, Heath JR, Greenland JR, Lanier LL. Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression. Journal of Experimental Medicine 2022;219:e20220551. [DOI: 10.1084/jem.20220551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ustiuzhanina MO, Vavilova JD, Boyko AA, Streltsova MA, Kust SA, Kanevskiy LM, Sapozhnikov AM, Iskhakov RN, Gubernatorova EO, Drutskaya MS, Bychinin MV, Zhukova OA, Novikova ON, Sotnikova AG, Yusubalieva GM, Baklaushev VP, Kovalenko EI. Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19. IJMS 2023;24:1996. [DOI: 10.3390/ijms24031996] [Reference Citation Analysis]
2 Calabrese DR, Tsao T, Magnen M, Valet C, Gao Y, Mallavia B, Tian JJ, Aminian EA, Wang KM, Shemesh A, Punzalan EB, Sarma A, Calfee CS, Christenson SA, Langelier CR, Hays SR, Golden JA, Leard LE, Kleinhenz ME, Kolaitis NA, Shah R, Venado A, Lanier LL, Greenland JR, Sayah DM, Ardehali A, Kukreja J, Weigt SS, Belperio JA, Singer JP, Looney MR. NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes. JCI Insight 2022;7:e164603. [PMID: 36346670 DOI: 10.1172/jci.insight.164603] [Reference Citation Analysis]
3 Fionda C, Ruggeri S, Sciumè G, Laffranchi M, Quinti I, Milito C, Palange P, Menichini I, Sozzani S, Frati L, Gismondi A, Santoni A, Stabile H. Age-dependent NK cell dysfunctions in severe COVID-19 patients. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1039120] [Reference Citation Analysis]
4 Khalil M, Malarkannan S. Innatus immunis: Evolving paradigm of adaptive NK cells. J Exp Med 2022;219:e20221254. [PMID: 36066493 DOI: 10.1084/jem.20221254] [Reference Citation Analysis]